HUP0301128A3 - 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid containg pharmaceutical compositions for treating a cyclooxygenase-2 dependent disorder and their use - Google Patents

5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid containg pharmaceutical compositions for treating a cyclooxygenase-2 dependent disorder and their use

Info

Publication number
HUP0301128A3
HUP0301128A3 HU0301128A HUP0301128A HUP0301128A3 HU P0301128 A3 HUP0301128 A3 HU P0301128A3 HU 0301128 A HU0301128 A HU 0301128A HU P0301128 A HUP0301128 A HU P0301128A HU P0301128 A3 HUP0301128 A3 HU P0301128A3
Authority
HU
Hungary
Prior art keywords
fluoroanilino
cyclooxygenase
chloro
methyl
treating
Prior art date
Application number
HU0301128A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUP0301128A2 publication Critical patent/HUP0301128A2/hu
Publication of HUP0301128A3 publication Critical patent/HUP0301128A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0301128A 2000-09-11 2001-09-10 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid containg pharmaceutical compositions for treating a cyclooxygenase-2 dependent disorder and their use HUP0301128A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23165500P 2000-09-11 2000-09-11
US23226100P 2000-09-14 2000-09-14
PCT/EP2001/010448 WO2002020090A2 (en) 2000-09-11 2001-09-10 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUP0301128A2 HUP0301128A2 (hu) 2003-10-28
HUP0301128A3 true HUP0301128A3 (en) 2005-04-28

Family

ID=26925315

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301128A HUP0301128A3 (en) 2000-09-11 2001-09-10 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid containg pharmaceutical compositions for treating a cyclooxygenase-2 dependent disorder and their use

Country Status (28)

Country Link
US (2) US20020061932A1 (enExample)
EP (1) EP1331972B1 (enExample)
JP (2) JP2004527458A (enExample)
KR (1) KR20030036730A (enExample)
CN (1) CN100490797C (enExample)
AR (1) AR030630A1 (enExample)
AT (1) ATE366128T1 (enExample)
AU (2) AU2002213900C1 (enExample)
BR (1) BR0113809A (enExample)
CA (1) CA2416771C (enExample)
CY (1) CY1107729T1 (enExample)
CZ (1) CZ2003673A3 (enExample)
DE (1) DE60129238T2 (enExample)
DK (1) DK1331972T3 (enExample)
ES (1) ES2290181T3 (enExample)
HU (1) HUP0301128A3 (enExample)
IL (2) IL154238A0 (enExample)
MX (1) MXPA03002105A (enExample)
MY (1) MY126117A (enExample)
NO (1) NO20031095D0 (enExample)
NZ (1) NZ524785A (enExample)
PE (1) PE20020351A1 (enExample)
PL (1) PL359721A1 (enExample)
PT (1) PT1331972E (enExample)
RU (1) RU2316324C2 (enExample)
SI (1) SI1331972T1 (enExample)
SK (1) SK2902003A3 (enExample)
WO (1) WO2002020090A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036312A1 (es) * 2001-08-31 2004-08-25 Novartis Ag Composicion farmaceutica
GB0201520D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Pharmaceutical uses
CA2476744A1 (en) * 2002-03-07 2003-09-12 Novartis Ag Solid pharmaceutical compositions comprising lumiracoxib
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AR042206A1 (es) 2002-11-26 2005-06-15 Novartis Ag Acidos fenilaceticos y derivados
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) * 2003-09-11 2005-06-16 Pharmacia Corporation Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
RU2423979C2 (ru) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
WO2008086537A2 (en) * 2007-01-11 2008-07-17 Analog Devices, Inc. Aluminum based bonding of semiconductor wafers
AU2009282901A1 (en) * 2008-08-22 2010-02-25 Novartis Ag Use of a COX-2 inhibitor for the treatment of a COX-2 dependent disorder in a patient not carrying HLA alleles associated with hepatotoxicity
US8227451B2 (en) 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) * 2013-12-31 2016-05-18 上海复力生物医药科技有限公司 磷虾油的制备方法
KR102557900B1 (ko) 2016-09-07 2023-07-19 트러스티즈 오브 터프츠 칼리지 면역-dash 억제제와 pge2 길항제를 이용한 병행 요법
EP3687505A1 (en) 2017-09-26 2020-08-05 Tesaro Inc. Niraparib formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0701449T3 (da) * 1993-06-08 2003-11-10 Novartis Ag Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
EP0910368A1 (en) * 1996-05-17 1999-04-28 Merck & Co., Inc. Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
AR036312A1 (es) * 2001-08-31 2004-08-25 Novartis Ag Composicion farmaceutica

Also Published As

Publication number Publication date
SI1331972T1 (sl) 2007-12-31
CA2416771A1 (en) 2002-03-14
WO2002020090A9 (en) 2003-10-30
WO2002020090A3 (en) 2003-05-30
CY1107729T1 (el) 2013-04-18
CZ2003673A3 (cs) 2003-06-18
AU2002213900B2 (en) 2006-02-16
US20040186179A1 (en) 2004-09-23
PT1331972E (pt) 2007-10-16
CN1455691A (zh) 2003-11-12
CA2416771C (en) 2010-11-02
MXPA03002105A (es) 2003-06-19
US20020061932A1 (en) 2002-05-23
AR030630A1 (es) 2003-08-27
AU2002213900C1 (en) 2006-07-27
EP1331972B1 (en) 2007-07-04
DE60129238T2 (de) 2008-03-06
MY126117A (en) 2006-09-29
CN100490797C (zh) 2009-05-27
IL154238A (en) 2008-11-26
WO2002020090A2 (en) 2002-03-14
JP2011144194A (ja) 2011-07-28
DE60129238D1 (de) 2007-08-16
RU2316324C2 (ru) 2008-02-10
JP2004527458A (ja) 2004-09-09
NZ524785A (en) 2005-10-28
ES2290181T3 (es) 2008-02-16
AU1390002A (en) 2002-03-22
IL154238A0 (en) 2003-09-17
EP1331972A2 (en) 2003-08-06
DK1331972T3 (da) 2007-11-05
HUP0301128A2 (hu) 2003-10-28
KR20030036730A (ko) 2003-05-09
PE20020351A1 (es) 2002-06-14
PL359721A1 (en) 2004-09-06
NO20031095L (no) 2003-03-10
SK2902003A3 (en) 2003-10-07
NO20031095D0 (no) 2003-03-10
BR0113809A (pt) 2003-07-29
ATE366128T1 (de) 2007-07-15

Similar Documents

Publication Publication Date Title
HUP0301128A3 (en) 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid containg pharmaceutical compositions for treating a cyclooxygenase-2 dependent disorder and their use
ZA9610936B (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
SG71923A1 (en) Use of nanodispersions in pharmaceutical end formulations
ITMI931486A0 (it) Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
DE69624910D1 (de) Orale pharmazeutische dosierungsformen die einen protonenpumpeninhibitor und ein prokinetisches mittel enthalten
NO20003218L (no) Oral farmasøytisk doseringsform med forlenget frigivningsvirkning
HUP0302553A3 (en) Salts of a isothiazole-4-carboxamide and process for their preparation and use for the preparation of anti-hyperproliferation agents
HUP0301482A3 (en) Quinolinnyl and benzothiazolyl ppar-gamma modulators pharmaceutical compositions containing them and their use
HUP0201687A3 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
HUP0102277A3 (en) Herbicid composition containing a 3-heterocyclyl-substituted benzoic acid derivative preparation and use thereof
GB0222880D0 (en) Dermatological use and a dermatological preparation
AU2000226049A1 (en) Improved laser assisted pharmaceutical delivery and fluid removal
IL162286A0 (en) Improvements in and in relation to a medicament cartridge
BR9607826A (pt) Dispensador de fio dental de uso simples
ITMI20000964A0 (it) Dispositivo ortodontico per l'allineamento e lo spostamento dei denti
IL170518A (en) Liquid oral dosage formulations comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino) phenylacetic acid, methods for preparing them and use thereof for the manufacture of medicaments
EE200900049A (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
EE200100578A (et) Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat
HUP0304063A3 (en) Medicinal compositions comprising diclofenac and ornoprostil
AU2002213755A1 (en) A vaccine for acids and its preparation and use
FR2817464B1 (fr) Dispositif d'assistance a des personnes souffrant de douleurs dorsales, notamment de douleurs lombaires
AU2002210989A1 (en) Cyclopropanecarboxylic acid amide compounds and medicinal use thereof
AU2002212074A1 (en) A pharmaceutical composition for treating acids and its preparation
HUP0100122A3 (en) Use of tiludronic acid and derivatives thereof in poultry for preparation of a medicinal product for preventing and treating osteoporosis
AU2002237251A1 (en) A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees